Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prerna Arora

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
Journal of Translational Medicine|December 12, 2025
The presence of persistent synovial inflammation after "Eradication" unmasks the "Unseen" dormant state of infection allowing the prediction of infection free survival in total joint replacementsRobert Manasherob, Shay I Warren, Christopher M Flanagan, et al.
Cell Reports|July 16, 2021
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccinationMarkus Hoffmann, Heike Hofmann-Winkler, Nadine Krüger, et al.
Nature Communications|June 13, 2023
Omicron subvariant BA.5 efficiently infects lung cellsMarkus Hoffmann, Lok-Yin Roy Wong, Prerna Arora, et al.
The Lancet. Infectious Diseases|April 15, 2022
Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3Prerna Arora, Lu Zhang, Cheila Rocha, et al.
The Journal of Arthroplasty|August 3, 2025
Patients Who Have Limited English Proficiency Are More Likely to Receive Elective Total Joint ArthroplastyJohn P M Angeles, Maveric K I L Abella, Anna G McGovern, et al.
Cell|April 1, 2021
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodiesMarkus Hoffmann, Prerna Arora, Rüdiger Groß, et al.
The Journal of Arthroplasty|February 11, 2026
Reply to Letter to the Editor on "Patients Who Have Limited English Proficiency Are More Likely to Receive Elective Total Joint Arthroplasty"John P M Angeles, Maveric K I L Abella, Anna G McGovern, et al.
Kidney International|October 7, 2021
Improved cellular and humoral immunity upon a second BNT162b2 and mRNA-1273 boost in prime-boost vaccination no/low responders with end-stage renal diseaseUlrik Stervbo, Arturo Blazquez-Navarro, Elena Vidal Blanco, et al.
Ebiomedicine|March 7, 2021
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activityMarkus Hoffmann, Heike Hofmann-Winkler, Joan C Smith, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Journal of Translational Medicine|December 12, 2025
The presence of persistent synovial inflammation after "Eradication" unmasks the "Unseen" dormant state of infection allowing the prediction of infection free survival in total joint replacementsRobert Manasherob, Shay I Warren, Christopher M Flanagan, et al.
Cell Reports|July 16, 2021
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccinationMarkus Hoffmann, Heike Hofmann-Winkler, Nadine Krüger, et al.
Nature Communications|June 13, 2023
Omicron subvariant BA.5 efficiently infects lung cellsMarkus Hoffmann, Lok-Yin Roy Wong, Prerna Arora, et al.
The Lancet. Infectious Diseases|April 15, 2022
Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3Prerna Arora, Lu Zhang, Cheila Rocha, et al.
The Journal of Arthroplasty|August 3, 2025
Patients Who Have Limited English Proficiency Are More Likely to Receive Elective Total Joint ArthroplastyJohn P M Angeles, Maveric K I L Abella, Anna G McGovern, et al.
Cell|April 1, 2021
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodiesMarkus Hoffmann, Prerna Arora, Rüdiger Groß, et al.
The Journal of Arthroplasty|February 11, 2026
Reply to Letter to the Editor on "Patients Who Have Limited English Proficiency Are More Likely to Receive Elective Total Joint Arthroplasty"John P M Angeles, Maveric K I L Abella, Anna G McGovern, et al.
Kidney International|October 7, 2021
Improved cellular and humoral immunity upon a second BNT162b2 and mRNA-1273 boost in prime-boost vaccination no/low responders with end-stage renal diseaseUlrik Stervbo, Arturo Blazquez-Navarro, Elena Vidal Blanco, et al.
Ebiomedicine|March 7, 2021
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activityMarkus Hoffmann, Heike Hofmann-Winkler, Joan C Smith, et al.
Pageof 10